Skye Bioscience Inc (SKYE)

[cjarmstrong]

Plant derived drugs aren't uncommon or inferior. The advantage with biosynthesis is mainly reduced time and cost. There could be indications where the whole plant may be superior to THC alone, perhaps where CBD could moderate the psychoactive effect of THC, if the dose were high enough. Other cannabinoids could have a synergistic effect as well, possibly even terpenes though it would take years to study. Some researchers are skeptical of the entourage effect, it would be interesting to study dronabinol against a bioequivalent edible rather than inhaling cannabis (if it hasn't already been done).

The delivery method is critical, transmucosal/transdermal are unquestionably the most effective, other than intravenous. A topical preparation would of course be most effective for glaucoma (though I'm skeptical that NB1111 will be successful because of tolerance).

"But if it's valued at a couple hundred million $$ then that's not bad for a few years work...".

Not bad at all, is that just a hypothetical figure or what you actually think it could be worth to Nemus?